Anuh Pharma Statistics
Total Valuation
Anuh Pharma has a market cap or net worth of INR 7.80 billion. The enterprise value is 7.67 billion.
| Market Cap | 7.80B |
| Enterprise Value | 7.67B |
Important Dates
The next confirmed earnings date is Saturday, May 30, 2026.
| Earnings Date | May 30, 2026 |
| Ex-Dividend Date | Aug 14, 2025 |
Share Statistics
Anuh Pharma has 100.22 million shares outstanding. The number of shares has decreased by -0.08% in one year.
| Current Share Class | 100.22M |
| Shares Outstanding | 100.22M |
| Shares Change (YoY) | -0.08% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | 72.90% |
| Owned by Institutions (%) | 0.00% |
| Float | 26.86M |
Valuation Ratios
The trailing PE ratio is 18.65.
| PE Ratio | 18.65 |
| Forward PE | n/a |
| PS Ratio | 1.02 |
| PB Ratio | 2.39 |
| P/TBV Ratio | 2.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 18.35 |
| EV / Sales | 1.00 |
| EV / EBITDA | 13.22 |
| EV / EBIT | 15.57 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | n/a |
| Interest Coverage | 123.22 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 11.72% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.05% |
| Revenue Per Employee | 26.02M |
| Profits Per Employee | 1.42M |
| Employee Count | 295 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Anuh Pharma has paid 141.60 million in taxes.
| Income Tax | 141.60M |
| Effective Tax Rate | 25.29% |
Stock Price Statistics
The stock price has decreased by -6.36% in the last 52 weeks. The beta is 0.32, so Anuh Pharma's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | -6.36% |
| 50-Day Moving Average | 77.37 |
| 200-Day Moving Average | 87.64 |
| Relative Strength Index (RSI) | 50.97 |
| Average Volume (20 Days) | 4,230 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Anuh Pharma had revenue of INR 7.68 billion and earned 418.22 million in profits. Earnings per share was 4.17.
| Revenue | 7.68B |
| Gross Profit | 1.63B |
| Operating Income | 492.89M |
| Pretax Income | 559.82M |
| Net Income | 418.22M |
| EBITDA | 576.28M |
| EBIT | 492.89M |
| Earnings Per Share (EPS) | 4.17 |
Balance Sheet
The company has 130.96 million in cash and 2.27 million in debt, giving a net cash position of 128.69 million or 1.28 per share.
| Cash & Cash Equivalents | 130.96M |
| Total Debt | 2.27M |
| Net Cash | 128.69M |
| Net Cash Per Share | 1.28 |
| Equity (Book Value) | 3.27B |
| Book Value Per Share | 32.64 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 21.29%, with operating and profit margins of 6.42% and 5.45%.
| Gross Margin | 21.29% |
| Operating Margin | 6.42% |
| Pretax Margin | 7.29% |
| Profit Margin | 5.45% |
| EBITDA Margin | 7.51% |
| EBIT Margin | 6.42% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.75, which amounts to a dividend yield of 0.96%.
| Dividend Per Share | 0.75 |
| Dividend Yield | 0.96% |
| Dividend Growth (YoY) | 20.00% |
| Years of Dividend Growth | 5 |
| Payout Ratio | n/a |
| Buyback Yield | 0.08% |
| Shareholder Yield | 1.05% |
| Earnings Yield | 5.36% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on July 15, 2025. It was a forward split with a ratio of 2.
| Last Split Date | Jul 15, 2025 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |